1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock Split
08. November 2022 12:10 ET | Timber Pharmaceuticals
BASKING RIDGE, NJ, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR) ("Timber" or the "Company"), a clinical-stage biopharmaceutical company...
1589917612572_5ec429193ef97e0004f1060c_logo.png
Timber Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
11. September 2020 16:29 ET | Timber Pharmaceuticals
Virtual Presentation on Wednesday, September 16th at 12:30 PM ET WOODCLIFF LAKE, NJ, Sept. 11, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire-- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”)...
1589917612572_5ec429193ef97e0004f1060c_logo.png
imber Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
11. September 2020 16:05 ET | Timber Pharmaceuticals
Virtual Presentation on Wednesday, September 16th at 12:30 PM ET WOODCLIFF LAKE, NJ, Sept. 11, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”)...